StockData
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc. (SBFM) income statement

SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$2.41−0.13 (-5.12%)

Close on Nov 18, 2026Market cap $9.34MP/E –Yield –

Sunshine Biopharma Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
30.3%
Operating margin
-16.6%
Net margin
-16.5%
Return on equity, FY2025
-25.7%

Financial strength

Current ratio
5.46
Debt to equity
–
Debt to assets
–
Cash to current liabilities
244.7%

Valuation

P/E ratio
–
Price to sales
0.26
Price to book
0.34
Dividend yield
–

See a number that looks wrong?